A.L. Cox, J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, C.L. Slingluff, "Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines," Science, 264:716-9, 1994. (Cited in more than 60 articles through September 1995)

Comments by Victor Engelhard, University of Virginia, Charlottesville

The importance of this paper, according to Victor Engelhard, a professor of microbiology at the University of Virginia, is that "it was one of the first conclusive reports describing a specific tumor antigen to be recognized by cytotoxic T cells in humans.

Victor Engelhard PINPOINTING PEPTIDES: Victor Engelhard's team identified a tumor antigen specific to melanoma cells.

"Historically, immunologists have been alternately excited and despondent with respect to harnessing the immune system against cancer," he explains. "The area got its most recent jump start around the mid-1980s, when [Steven] Rosenberg showed that lymphocytes isolated from excised human tumors...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!